Merck (MRK) Other Accumulated Expenses (2009 - 2026)

Merck (MRK) has 18 years of Other Accumulated Expenses data on file, last reported at $14.5 billion in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $14.5 billion, up 13.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.5 billion (up 13.91% YoY), and the FY2025 annual result was $14.5 billion, down 7.81% from the prior year.
• Other Accumulated Expenses advanced to $14.5 billion in Q1 2026 per MRK's latest filing, from $14.5 billion in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $16.5 billion in Q3 2024 and troughed at $12.8 billion in Q1 2025.
• A 5-year average of $14.5 billion and a median of $14.5 billion in 2025 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses grew 17.97% in 2022, then fell 9.43% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $14.2 billion in 2022, then climbed by 11.35% to $15.8 billion in 2023, then retreated by 0.46% to $15.7 billion in 2024, then declined by 7.81% to $14.5 billion in 2025, then gained by 0.56% to $14.5 billion in 2026.
• Business Quant data shows MRK's Other Accumulated Expenses at $14.5 billion in Q1 2026, $14.5 billion in Q4 2025, and $16.2 billion in Q3 2025.